HOME > English Home > News Release 2010
News Release 2010
- September 17, 2010
- License Agreement of “iron-oxyhydroxide” for the treatment of hyperphosphatemia in dialysis patients
- July 2, 2010
- Preliminary Results of Phase III clinical study of KUC-7483
- Maｙ 26, 2010
- Announcement for Launching "Epoetin Alfa BS Injection [JCR]", a Treatment Agent for Renal Anemia
- April 30, 2010
- License Agreement of “Genetically Engineered Proaerolysin” for the Treatment of
Benign Prostatic Hyperplasia - February 4, 2010
- European Commission Approved SILODOSIN (Brand Name in Japan: Urief®) for The Treatment
of Dysuria Associated with Benign Prostatic Hyperplasia
